ACE Inhibitors
Long-acting lipophilic ACE inhibitors should be a routine treatment
Published in Health and Medicine Week, January 3rd, 2005
According to a report published in the journal Current Medical Research and Opinion, "This paper reports the rationale for the cardiovascular protective effects of ACE inhibitors (ACEI) and reviews the overall results of recent randomized clinical trials."
M.E. Bertrand of the University of Lille continued, "ACEIs improve the vasoconstrictive/vasodilatory balance by blocking the formation of angiotensin II and preventing the degradation of bradykinin. In vitro, animal and human experimental studies have shown that ACEI have several properties:...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Developmental Disorders
A site on chromosome 15q is implicated for causing dyslexia - Diet and Nutrition
Vegetarians bear a greater capacity to load creatine in muscle tissues - Eating Disorder
A KCNN3 gene polymorphism may heighten susceptibility to anorexia nervosa - Geriatrics
The hereditary aspect of Alzheimer disease stresses caregivers - ADHD
Children have greater reduction of symptoms with higher doses of Concerta - AIDS Therapy
Access program for anti-HIV drug tipranavir expanded - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
